XML 17 R67.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Business Combination - Schedule of Unaudited Pro Forma Statements of Operations (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2018
Sep. 30, 2018
Dec. 31, 2018
Dec. 31, 2017
Business Acquisition [Line Items]        
Revenue $ 1,509,974 $ 4,523,702 $ 5,823,996 $ 5,565,194
Net Income $ 203,805 $ 294,402 $ 118,903 $ 225,851
Net Income per common share - basic $ 0.01 $ 0.01 $ 0.00 $ 0.01
Net Income per common share - diluted $ 0.01 $ 0.01 $ 0.00 $ 0.01
Weighted average common shares - basic 32,083,629 32,083,629 32,260,622 31,955,416
Weighted average common shares - diluted 34,737,964 34,732,540 34,958,502 34,086,251
Trxade [Member]        
Business Acquisition [Line Items]        
Revenue $ 847,471 $ 2,538,082 $ 3,436,360 $ 2,931,280
Net Income $ 94,249 $ 197,031 $ 125,626 $ 288,983
Net Income per common share - basic $ 0.00 $ 0.01 $ 0.00 $ 0.01
Net Income per common share - diluted $ 0.00 $ 0.01 $ 0.00 $ 0.01
Weighted average common shares - basic 32,083,629 32,083,629 32,260,622 31,955,416
Weighted average common shares - diluted 34,737,964 34,732,540 34,958,502 34,086,251
Community Specialty Pharmacy, LLC [Member]        
Business Acquisition [Line Items]        
Revenue $ 662,503 $ 1,985,620 $ 2,387,636 $ 2,633,914
Net Income $ 109,556 $ 97,371 $ (6,723) $ (63,132)